X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Hindustan Unilever with AMAR REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIND. UNILEVER vs AMAR REMEDIES - Comparison Results

HIND. UNILEVER    Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    HIND. UNILEVER AMAR REMEDIES HIND. UNILEVER/
AMAR REMEDIES
 
P/E (TTM) x 64.0 -0.5 - View Chart
P/BV x 48.2 0.1 79,989.4% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 HIND. UNILEVER   AMAR REMEDIES
EQUITY SHARE DATA
    HIND. UNILEVER
Mar-18
AMAR REMEDIES
Jun-12
HIND. UNILEVER/
AMAR REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,415164 862.9%   
Low Rs89986 1,045.5%   
Sales per share (Unadj.) Rs164.2261.6 62.8%  
Earnings per share (Unadj.) Rs24.117.4 138.8%  
Cash flow per share (Unadj.) Rs26.522.3 119.1%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs33.6100.7 33.4%  
Shares outstanding (eoy) m2,164.5326.16 8,274.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x7.00.5 1,474.8%   
Avg P/E ratio x47.97.2 667.0%  
P/CF ratio (eoy) x43.65.6 777.3%  
Price / Book Value ratio x34.41.2 2,772.0%  
Dividend payout %82.90-   
Avg Mkt Cap Rs m2,504,6863,270 76,595.9%   
No. of employees `0005.7NA-   
Total wages/salary Rs m18,600163 11,411.0%   
Avg. sales/employee Rs Th62,087.3NM-  
Avg. wages/employee Rs Th3,248.9NM-  
Avg. net profit/employee Rs Th9,126.6NM-  
INCOME DATA
Net Sales Rs m355,4506,844 5,193.6%  
Other income Rs m3,84021 18,285.7%   
Total revenues Rs m359,2906,865 5,233.6%   
Gross profit Rs m74,9901,131 6,630.4%  
Depreciation Rs m5,200128 4,062.5%   
Interest Rs m260398 65.3%   
Profit before tax Rs m73,370626 11,720.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-330-50 660.0%   
Tax Rs m20,790121 17,181.8%   
Profit after tax Rs m52,250455 11,483.5%  
Gross profit margin %21.116.5 127.7%  
Effective tax rate %28.319.3 146.6%   
Net profit margin %14.76.6 221.1%  
BALANCE SHEET DATA
Current assets Rs m116,6004,904 2,377.7%   
Current liabilities Rs m88,8703,581 2,481.7%   
Net working cap to sales %7.819.3 40.4%  
Current ratio x1.31.4 95.8%  
Inventory Days Days26124 20.8%  
Debtors Days Days13100 13.4%  
Net fixed assets Rs m49,8901,689 2,953.8%   
Share capital Rs m2,160262 824.4%   
"Free" reserves Rs m70,6502,358 2,996.2%   
Net worth Rs m72,8102,635 2,763.2%   
Long term debt Rs m0507 0.0%   
Total assets Rs m178,6206,862 2,603.0%  
Interest coverage x283.22.6 11,006.9%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x2.01.0 199.5%   
Return on assets %29.412.4 236.5%  
Return on equity %71.817.3 415.6%  
Return on capital %100.731.0 324.8%  
Exports to sales %04.0 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA273 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,870273 1,417.6%   
Fx outflow Rs m12,8502 642,500.0%   
Net fx Rs m-8,980271 -3,313.7%   
CASH FLOW
From Operations Rs m60,640-313 -19,404.8%  
From Investments Rs m-10,680-489 2,186.3%  
From Financial Activity Rs m-49,750769 -6,473.6%  
Net Cashflow Rs m210-33 -646.2%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 67.3 0.0 -  
Indian inst/Mut Fund % 4.1 9.2 44.6%  
FIIs % 14.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 14.5 65.3 22.2%  
Shareholders   322,351 13,061 2,468.0%  
Pledged promoter(s) holding % 0.0 99.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare HIND. UNILEVER With:   GODREJ INDUSTRIES  BATA INDIA  P&G HYGIENE  GILLETTE INDIA  K.S.OILS LTD  

Compare HIND. UNILEVER With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

HIND. UNILEVER 2017-18 Annual Report Analysis (Annual Result Update)

Aug 9, 2018 | Updated on Aug 9, 2018

Here's an analysis of the annual report of HIND. UNILEVER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of HIND. UNILEVER. Also includes updates on the valuation of HIND. UNILEVER.

HIND. UNILEVER Announces Quarterly Results (1QFY19); Net Profit Up 18.0% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, HIND. UNILEVER has posted a net profit of Rs 15 bn (up 18.0% YoY). Sales on the other hand came in at Rs 95 bn (up 2.9% YoY). Read on for a complete analysis of HIND. UNILEVER's quarterly results.

Marico: Margin Expansion Drives Profit Growth (Quarterly Results Update - Detailed)

Nov 28, 2016

Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.

Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

Aug 9, 2017

While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

P&G: Strong Core Growth (Quarterly Results Update - Detailed)

Dec 9, 2016

Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

HIND. UNILEVER SHARE PRICE


Sep 21, 2018 (Close)

TRACK HIND. UNILEVER

  • Track your investment in HIND. UNILEVER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON HIND. UNILEVER

HIND. UNILEVER 8-QTR ANALYSIS

COMPARE HIND. UNILEVER WITH

MARKET STATS